September 30, 2008

HELIX BIOPHARMA ANNOUNCES $11. 4 MILLION PRIVATE PLACEMENT (PDF)

(Aurora, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP”) today announced that it has received subscriptions for the purchase, by way of private placement, of a total of 6,800,000 units at $1.68 per unit, for gross proceeds totaling CDN$11,424,000. The Company anticipates closing the private placement within the next ten days.